IPO Boutique

Cempra Holdings IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Cempra Holdings, and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Cempra HoldingsCEMP -
NASDAQ
$11.00-$13.00 $6.00 $6.206 million2/3/2012
Stifel Nicolaus Weisel, Leerink Swann, Cowen and Company
Co-Manager(s):
Needham & Company
Health Care
Filing(s):

Terms Added 2012-01-13



Cempra Holdings Quote & Chart - Click for current quote - CEMP

About Cempra Holdings (adapted from Cempra Holdings prospectus):
They are a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical unmet medical needs in the treatment of infectious diseases, particularly respiratory tract infections and skin and skin structure infections.

This description is adapted from Cempra prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as Cempra "CEMP" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved